Team

Prof Alexander So was previously head of the Department of Rheumatology of the CHUV and Professor of Medicine at the University of Lausanne. He has been involved in clinical development of new therapies in rheumatic diseases for over 25 years, with experience in phase II to IV studies. He is co-founder of the European Crystal Network and member of G-CAN, and has served on the scientific committee of EULAR.

Previous to his appointment at the CHUV, he was senior lecturer in Rheumatology at Hammersmith Hospital London (Royal Postgraduate Medical School). He obtained his medical degree from Cambridge University, UK.

Prof Nathalie Busso obtained her PhD in 1987 from Pierre et Marie Curie University, Paris and subsequently worked as Project Leader at GSK Laboratories, Paris. In 1995, she joined the Rheumatology Department of the CHUV to lead experimental rheumatology research. She was promoted to Professor in 2010. Her extensive experience in animal models of rheumatic diseases and studies on inflammatory mechanisms range from coagulation and its role in arthritis, the role of the inflammasome in gout and other inflammatory rheumatic diseases and more recently the role of calcium crystals in joint pathology. She is also active in European rheumatology (Founder member of European Crystal Network, member of COST action CA16115 EUROSOFTCALCNET). She has more than 80 publications in high impact scientific journals.

Dr Sonia Nasi obtained her PhD in Life Sciences from the University of Lausanne in 2015, and has studied extensively the mechanisms, effects and treatments of calcification disorders in musculoskeletal diseases. She is currently a post-doctoral researcher in Rheumatology (CHUV/UNIL). She is co-inventor of (patent pending) a CSE modulator as a treatment of calcification disorders. She is a cofounder of SULFISCON. The laboratory has a unique expertise in the study of calcification disorders in rheumatic diseases, their principal field of interest, and has published extensively. It is one of the leading groups internationally studying pathological calcification and has developed extensive contacts with European researchers active in this area (the founders are members of the EU sponsored COST action CA16115 EUROSOFTCALCNET).